Trastuzumab Recruiting Phase 2 Trials for Stage IV Breast Cancer / Breast Carcinoma Metastatic in the Brain / Estrogen Receptor Negative / HER2/Neu Positive / Recurrent Breast Carcinoma / HER2/Neu Negative / Progesterone Receptor Negative / Triple-Negative Breast Carcinoma Treatment

Indications	Status	Purpose	Phase
DBCOND0028550 (Stage IV Breast Cancer) DBCOND0082404 (Breast Carcinoma Metastatic in the Brain) DBCOND0036417 (Estrogen Receptor Negative) DBCOND0037939 (HER2/Neu Positive) DBCOND0030216 (Recurrent Breast Carcinoma) DBCOND0034239 (HER2/Neu Negative) DBCOND0038639 (Progesterone Receptor Negative) DBCOND0038640 (Triple-Negative Breast Carcinoma)	Recruiting	Treatment	2

clinicaltrials.gov Identifier	Title	Drugs
NCT02774681	Palbociclib in Treating Patients With Metastatic HER-2 Positive Breast Cancer With Brain Metastasis	Palbociclib (DB09073) Trastuzumab (DB00072)